Form 4: GeneDx Holdings Corp. Director Jason Ryan Reports Stock Transactions
SEC Form 4 Filing
Director Jason Ryan reports the acquisition of 130 shares of Class A Common Stock through the vesting of restricted stock units.
Summary
- On October 15, 2024, Jason Ryan, a director of GeneDx Holdings Corp., acquired 130 shares of Class A Common Stock.
- This acquisition resulted from the vesting of restricted stock units (RSUs).
- Following the transaction, Ryan directly owns 73,744 shares of Class A Common Stock.
- The RSUs vest in equal annual installments over a three-year period from the grant date of October 15, 2021, contingent upon continued service to the Issuer.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting a routine transaction. It doesn't convey any particularly positive or negative sentiment.
Positives
- The vesting of RSUs indicates that the director is meeting the service requirements.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company insiders.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a small number of shares acquired through vesting.
Key Dates
| Date | Description |
|---|---|
| 10/15/2021 | Grant date of the Restricted Stock Units (RSUs) which vest over a three-year period. |
| 10/15/2024 | Transaction date: Jason Ryan acquired 130 shares of Class A Common Stock through RSU vesting. |
| 10/17/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.